Competitive landscape, product development activities, business strategies, and corporate alliances and affiliations


DUBLIN, June 9, 2022 /PRNewswire/ — The “Cardiovascular Controlled-Release Therapeutics” report has been added to from offer.

Research and Markets Logo

The prevalence and incidence of cardiovascular disease in developed economies continues to rise, creating challenges and opportunities for cardiovascular drug developers.

While the vast majority of drugs for the treatment of cardiovascular disease are immediate-release oral products, issues related to drug safety and patient compliance have drawn attention to formulations that can improve drug profiles. of drug safety and reduce the frequency of administration. Important treatment segments for cardiovascular controlled release drugs include angina pectoris, hypertension, arrhythmias, cholesterol and peripheral arterial disease.

Important growth factors for cardiovascular controlled-release drugs include changing patient demographics, environmental and lifestyle etiological factors, increased public awareness of cardiovascular diseases and their associated morbidities, and expanding patient access to cardiovascular treatment services.

Cardiovascular Controlled Release Therapeutics – What You Will Learn

  • Analyzes and evaluates controlled release cardiovascular drugs and assesses the market potential of existing and likely future products

  • Analyzes product strategies, technologies and market development issues

  • Provides in-depth analysis of Cardiovascular market segments, market demographics, and therapeutic strategies

  • Market sector company profiles, their product development activities, business strategies and corporate alliances and affiliations

  • Evaluates the impact of economic, technological and regulatory factors on the cardiovascular drug markets

Main topics covered:

  • Summary

  • Cardiovascular Therapeutics – Market Dynamics

  • The Cardiovascular Drug Landscape

  • Unmet Need for Cardiovascular Clinical Treatment

  • Drivers of Cardiovascular Drug Demand

  • Demographic changes

  • Evolution of drug formulation technology

  • Managed care initiatives

  • Self-administration growth

  • Altered Release Technologies

  • Oral

  • Advanced lamination systems

  • Ball systems

  • Bilayer tablets

  • Three-layer tablets

  • Microtablets

  • transdermal

  • Analysis of controlled release cardiovascular products

  • Marketing Factors for Cardiovascular Drugs

  • Cardiovascular segments for CR Therapeutics

  • Angina

  • Cholesterol management

  • Heartbeat

  • Hypertension

  • Peripheral artery disease

  • Market factors

  • Regulations and Approvals

  • United States (FDA)

  • EU (EMEA)

  • Japan (PMDA)

  • Australia (TGA)

  • Managed Care and Health Economics

  • Profiles of participating companies in the sector

For more information on this report, visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716



Show original content: and-affiliations-301564887.html

SOURCE Research and Markets


Comments are closed.